Dr. Yongpeng Wang 王永鹏
Chief Physician
Gynecology (III), Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of complex, recurrent, or metastatic gynecologic tumors, retroperitoneal and pelvic floor tumors. Expertise in laparoscopic and single-port surgery for benign and early-stage tumors, and perioperative ERAS application.
Dr. Wang holds a medical doctorate and serves as Chief Physician. After 15 years in colorectal surgery, Dr. Wang transferred to the gynecologic oncology department in 2020 and completed one year of training at Peking Union Medical College Hospital. Dr. Wang is a master's supervisor at China Medical University and Dalian Medical University.
Professional roles
- Member, Chinese Medical Association
- Vice Chair, Youth Committee of Gastrointestinal Stromal Tumor Professional Committee, China Anti-Cancer Association
- Vice Chair, Youth Committee of Geriatric Gastrointestinal Surgery Branch, China Research Hospital Association
- Standing Committee Member, Colorectal and Anal Surgery Professional Committee, Liaoning Life Science Society
Name order: in Chinese the family name comes first (Wang Yongpeng). Papers usually list the name as Yongpeng Wang or Wang Y.
Selected publications
20 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Womens Health, 2024 (senior author): Teratoma combined with struma ovarii and sarcomatoid carcinoma: a case report and review of the literature. PubMed 39277716
- Hum Cell, 2023 (senior author): TEAD4 predicts poor prognosis and transcriptionally targets PLAGL2 in serous ovarian cancer. PubMed 37145265
- Onco Targets Ther, 2020 (senior author): Long Non-Coding RNA LEF1-AS1 Promotes Migration, Invasion and Metastasis of Colon Cancer Cells Through miR-30-5p/SOX9 Axis. PubMed 32308428
- Front Genet, 2019 (senior author): Comprehensive Analysis of Therapy-Related Messenger RNAs and Long Noncoding RNAs as Novel Biomarkers for Advanced Colorectal Cancer. PubMed 31850052
- Biomed Pharmacother, 2019 (senior author): An adenosine derivative (IFC-305) reduced the risk of radiation-induced intestinal toxicity in the treatment of colon cancer by suppressing the methylation of PPAR-r promoter. PubMed 31545232
- World J Gastroenterol, 2019 (senior author): Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma. PubMed 31236000
- Int J Clin Exp Med, 2015 (first author): Macroscopic serosal classification of colorectal cancer and its clinical significance. PubMed 26884925
- Oncol Lett, 2015 (first author): Clinicopathological features and prognosis of small gastrointestinal stromal tumors outside the stomach. PubMed 26722232
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion